The goal of Doloromics is to find better ways to treat chronic pain

To achieve this goal our main approach uses our proprietary algorithm, DOLOReS, to analyze genomic sequencing data from human patients to identify novel drug targets. 

Using this analysis we have identified drug targets for our in-house development pipeline.

Here are our publications. 

Screen Shot 2021-06-07 at 10.16.22